Abstract
Purpose
To evaluate the sexual function and quality of life pre- and post-gynecological cancer treatment with high-dose rate brachytherapy in the short term.
Methods
This is a descriptive and prospective study involving 20 women diagnosed with gynecological cancer aged between 18 and 70 years, resident in Florianopolis and the surrounding region. We used the Quality of Life Questionnaire Core-30 (QLQ-C30) 3.0 to assess quality of life pre- and post-brachytherapy treatment and the Female Sexual Function Index (FSFI) to assess sexual function.
Results
Regarding quality of life, significant worsening was observed for the items loss of appetite (p = 0.002) and diarrhea (p = 0.045) from pre- to post-brachytherapy treatment, whereas constipation (p = 0.013) improved. For sexual function, the statistical difference was found exclusively in the domain of lubrication reduction (p = 0.046). Only nine women were sexually active before and after brachytherapy treatment.
Conclusions
There was a worsening of quality of life in comparing pre- and post-evaluations related to gastrointestinal symptoms over a period equivalent to 40 days. Regarding sexual function, lack of lubrication was identified in short-term post-gynecological cancer brachytherapy.
Similar content being viewed by others
References
Lanciano RM, Won M, Coia LR, Hanks GE (1991) Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys 20(4):667–676
Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, Jones E, Kirisits C, Thomadsen B, Erickson B (2012) American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy 11(1):47–52
Stewart AJ, Viswanathan AN (2006) Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer. Cancer 107(5):908–915. doi:10.1002/cncr.22054
Hannoun-Levi J-M, Chand-Fouche M-E, Gautier M, Dejean C, Marcy M, Fouche Y (2013) Interstitial preoperative high-dose-rate brachytherapy for early stage cervical cancer: dose-volume histogram parameters, pathologic response and early clinical outcome. Brachytherapy 12(2):148–155
Abbott-Anderson K, Kwekkeboom KL (2012) A systematic review of sexual concerns reported by gynecological cancer survivors. Gynecol Oncol 124(3):477–489. doi:10.1016/j.ygyno.2011.11.030
Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DC (2005) Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 23(30):7428–7436. doi:10.1200/JCO.2004.00.3996
Bjelic-Radisic V, Jensen PT, Vlasic KK, Waldenstrom AC, Singer S, Chie W, Nordin A, Greimel E (2012) Quality of life characteristics inpatients with cervical cancer. Eur J Cancer 48(16):3009–3018. doi:10.1016/j.ejca.2012.05.011
Viani GA, Manta GB, Stefano EJ, de Fendi LI (2009) Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy - a meta-analysis of clinical trials. J Exp Clin Cancer Res 28:47. doi:10.1186/1756-9966-28-47
Leroy T, Gabelle Flandin I, Habold D, Hannoun-Levi JM (2012) The impact of radiation therapy on sexual function. Cancer Radiother 16(5–6):377–385. doi:10.1016/j.canrad.2012.05.012
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376
List of translations available by language—validated modules and C30 (2015) EORTC. http://groups.eortc.be/qol/eortc-qlq-c30
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D’Agostino R Jr (2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26(2):191–208. doi:10.1080/009262300278597
Pacagnella RdC, Martinez EZ, Vieira EM (2009) Construct validity of a Portuguese version of the Female Sexual Function Index. Cad Saude Publica 25(11):2333–2344
Wiegel M, Meston C, Rosen R (2005) The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 31(1):1–20
Barillot I, Maingon P, Truc G, Horiot J (2000) Complications des traitements des cancers invasifs du col utérin sur utérus intact. Résultats et prévention. Cancer Radiother 4(2):147–158
Mahantshetty U, Shrivastava S, Kalyani N, Banerjee S, Engineer R, Chopra S (2014) Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience. Brachytherapy 13(4):337–342. doi:10.1016/j.brachy.2013.09.009
Yamashita H, Niibe Y, Toita T, Kazumoto T, Nishimura T, Kodaira T, Eto H, Kinoshita R, Tsujino K, Onishi H, Takemoto M, Hayakawa K (2013) High-dose-rate intra-cavitary brachytherapy combined with external beam radiation therapy for under 40-year-old patients with invasive uterine cervical carcinoma: clinical outcomes in 118 Patients in a Japanese multi-institutional study, JASTRO. Jpn J Clin Oncol. 43(5):547–552. doi:10.1093/jjco/hyt029
Klee M, Thranov I, Machin Prof D (2000) The patients’ perspective on physical symptoms after radiotherapy for cervical cancer. Gynecol Oncol 76(1):14–23. doi:10.1006/gyno.1999.5642
Greimel ER, Winter R, Kapp KS, Haas J (2009) Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study. Psycho-Oncol 18(5):476–482
Barnas E, Skret-Magierlo J, Skret A, Bidzinski M (2012) The quality of life of women treated for cervical cancer. Eur J Oncol Nurs 16(1):59–63. doi:10.1016/j.ejon.2011.03.001
Hsu WC, Chung NN, Chen YC, Ting LL, Wang PM, Hsieh PC, Chan SC (2009) Comparison of surgery or radiotherapy on complications and quality of life in patients with the stage IB and IIA uterine cervical cancer. Gynecol Oncol 115(1):41–45. doi:10.1016/j.ygyno.2009.06.028
Vistad I, Cvancarova M, Fossa SD, Kristensen GB (2008) Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians’ assessments agree with those of their patients? Int J Radiat Oncol Biol Phys 71(5):1335–1342. doi:10.1016/j.ijrobp.2007.12.030
Vaz AF, Conde DM, Costa-Paiva L, Morais SS, Esteves SB, Pinto-Neto AM (2011) Quality of life and adverse events after radiotherapy in gynecologic cancer survivors: a cohort study. Arch Gynecol Obstet 284(6):1523–1531. doi:10.1007/s00404-011-1886-x
Kaidar-Person O, Abdah-Bortnyak R, Amit A, Nevelsky A, Berniger A, Bar-Deroma R, Ben-Yosef R, Kuten A (2014) Tolerance of the vaginal vault to high-dose rate brachytherapy and concomitant chemo-pelvic irradiation: Long-term perspective. Rep Pract Oncol Radiother. 19(1):56–61. doi:10.1016/j.rpor.2013.09.005
Rodrigues AC, Teixeira R, Teixeira T, Conde S, Soares P, Torgal I (2012) Impact of pelvic radiotherapy on female sexuality. Arch Gynecol Obstet 285(2):505–514. doi:10.1007/s00404-011-1988-5
Bradley S, Rose S, Lutgendorf S, Costanzo E, Anderson B (2006) Quality of life and mental health in cervical and endometrial cancer survivors. Gynecol Oncol 100(3):479–486. doi:10.1016/j.ygyno.2005.08.023
Smits A, Lopes A, Das N, Bekkers R, Galaal K (2014) The impact of BMI on quality of life in obese endometrial cancer survivors: does size matter? Gynecol Oncol 132(1):137–141. doi:10.1016/j.ygyno.2013.11.018
Ljuca DMG (2009) Quality of life in patients with cervical cancer FIGO IIb stage after concomitant chemoradiotherapy. Radiol Oncol 43(4):6. doi:10.2478/v10019-009-0025-9
Herzog TJ, Wright JD (2007) The impact of cervical cancer on quality of life-the components and means for management. Gynecol Oncol 107(3):572–577
Friedman LC, Abdallah R, Schluchter M, Panneerselvam A, Kunos CA (2011) Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer. Int J Radiat Oncol Biol Phys 80(3):751–757
Grion RC, Baccaro LF, Vaz AF, Costa-Paiva L, Conde DM, Pinto-Neto AM (2015) Sexual function and quality of life in women with cervical cancer before radiotherapy: a pilot study. Arch Gynecol Obstet 293(4):879–886. doi:10.1007/s00404-015-3874-z
Quinn M (2007) Sexual function after treatment of gynaecological cancer. Sexologies 16(4):286–291
Duncan LE, Lewis C, Jenkins P, Pearson TA (2000) Does hypertension and its pharmacotherapy affect the quality of sexual function in women? Am J Hypertens 13(6 Pt 1):640–647
Llisterri Caro J, Sánchez Sánchez F, Brotons Muntó F (2005) Disfunción sexual en la hipertensión arterial. Hipertensión 22(2):59–72
Iavazzo C, Johnson K, Savage H, Gallagher S, Datta M, Winter-Roach BA (2014) Sexuality issues in gynaecological oncology patients: post treatment symptoms and therapeutic options. Arch Gynecol Obstet 291(3):653–656. doi:10.1007/s00404-014-3491-2
Huffman LB, Hartenbach EM, Carter J, Rash JK, Kushner DM (2016) Maintaining sexual health throughout gynecologic cancer survivorship: a comprehensive review and clinical guide. Gynecol Oncol 140(2):359–368
Kim M-K, Sim JA, Yun YH, Bae D-S, Nam JH, Park CT, Cho C-H, Lee J-M, Park SY (2016) Health-related quality of life and sociodemographic characteristics as prognostic indicators of long-term survival in disease-free cervical cancer survivors. Int J Gynecol Cancer 00:00
Acknowledgments
We acknowledge the National Council for Scientific and Technological Development (CNPq) for their financial support (14/2011, process 485780/2011), and also the support of the Physical Therapy and Nursing (Ambulatory) department of the Oncology Research Center (CEPON), Florianópolis (SC), Brazil.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no proprietary, financial, professional or other personal interest of any nature in any product, service or company.
Ethical approval
All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Additional information
This research was developed at Santa Catarina State University (UDESC), Florianópolis (SC), Brazil.
Rights and permissions
About this article
Cite this article
Zomkowski, K., Toryi, A.M., Sacomori, C. et al. Sexual function and quality of life in gynecological cancer pre- and post-short-term brachytherapy: a prospective study. Arch Gynecol Obstet 294, 833–840 (2016). https://doi.org/10.1007/s00404-016-4099-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-016-4099-5